Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Write for us
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Video
  • Podcasts
  • News for You
  • Covid-19
  • Video
  • Podcasts

Search Results for tocilizumab

Massachusetts General Hospital Completes Study & Concludes Tocilizumab Not Helpful for Hospitalized COVID-19 Patients

TrialSite has reported on a few different study results indicating that Roche’s Actemra (tocilizumab), an IL-6 inhibitor, doesn’t help to lower […]

Massachusetts General Hospital Completes Study & Concludes Tocilizumab Not Helpful for Hospitalized COVID-19 Patients
3 months ago
Share
0

Roche Confirms Tocilizumab (Actemra®) Failed to Meet Endpoints in the Phase 3 COVACTA Study Involving COVID-19 Associated Pneumonia

TrialSite recently suggested based on unfolding study results that repurposed IL-6 inhibitors, such as Roche’s Actemra®/ReActemtra® (tocilizumab), may not work to […]

Roche Confirms Tocilizumab (Actemra®) Failed to Meet Endpoints in the Phase 3 COVACTA Study Involving COVID-19 Associated Pneumonia
6 months ago
Share
0

India Approves Itolizumab & Tocilizumab for COVID-19: Controversy Commences over the Evidence while Demand Soars

200 mg vial Tocilizumab—15,000 Rs ($200.20)
400 mg vial Tocilizumab—30,000 Rs ($400.39)
Full Itolizumab Treatment—40,000 rupees

India Approves Itolizumab & Tocilizumab for COVID-19: Controversy Commences Over the Evidence while Demand Soars
6 months ago
Share
0

Baylor College of Medicine Joins Roche Study to Evaluate Tocilizumab in Severe SARS-CoV-2 Cases

Baylor College of Medicine is a clinical investigational site for a clinical trial investigating the therapeutic benefits of an immunomodulator […]

Baylor College of Medicine Joins Roche Study to Evaluate Tocilizumab in Severe SARS-CoV-2 Cases
9 months ago
Share
0

Acceleration of First-Patient-First-Visit Study Milestone as Roche Study Investigating Tocilizumab in COVID-19 Pneumonia Patients Enrolls Patients in Spain

Roche recently announce the launch of a global study in collaboration with the U.S. Biomedical Advanced Research and Development Authority […]

Acceleration of First Patient First Visit Study Milestone as Roche Study Investigating Tocilizumab in COVID-19 Pneumonia Patients Enrolls Patients in Spain
10 months ago
Share
1

Dr. Peter Horby, One of World’s Top Principal Investigators On Ivermectin

The potential of Ivermectin as a treatment for COVID-19 has gained more attention of late since the meta-analysis led by Dr. […]

Dr. Peter Horby, One of World’s Top Principal investigators On Ivermectin
3 weeks ago
Share
8

COVID-19 Therapy & Vaccine Trends in Middle East & Northern Africa Region (MENA)

Known as the MENA region, the Middle East and Northern Africa, Arabian Business recently elaborated on the various COVID-19 therapies […]

COVID-19 Therapy & Vaccine Trends in Middle East & Northern Africa Region (MENA)
1 month ago
Share
2

FDA approves Xolair® (omalizumab) for adults with nasal polyps

Xolair is the first biologic for the treatment of nasal polyps that targets and blocks immunoglobulin E (IgE), a key […]

2 months ago
Share
0

University of Oxford RECOVERY Trial Targeting Hospitalized COVID-19 Patients Now Includes Economical and Widely Available Colchicine

TrialSite recently reported that the independent data monitoring committee recommended to continue the Montreal Heart Institute study investigating the use of […]

University of Oxford RECOVERY Trial Targeting Hospitalized COVID-19 Patients Now Includes Economical and Widely Available Colchicine
2 months ago
Share
1

Why Isn’t Ivermectin Being Widely Researched and Utilized?

On November 13, a scientific review manuscript was posted to OSF, a medical pre-print server by Pierre Kory, MD, of […]

Why Isn’t Ivermectin Being Widely Researched and Utilized
2 months ago
Share
10

Posts navigation

Older posts

Trending News

  • Not Using Ivermectin, One Year In, Is Unethical And Immoral
    Not Using Ivermectin, One Year In, Is Unethical And Immoral
  • New York Supreme Court Judge Order: Give The Patient Ivermectin As Court Battle Leads to Ivermectin for Successful Treatment Against COVID-19
    New York Supreme Court Judge Order: Give The Patient Ivermectin As Court Battle Leads to Ivermectin for Successful Treatment Against COVID-19
  • An Unlikely Nation Is Kicking This Pandemic. Guess Which. Then Why.
    An Unlikely Nation Is Kicking This Pandemic. Guess Which. Then Why.
  • Oxford’s Principal Trial: Bringing Ivermectin Directly into the Developed World in the Battle Against COVID-19
    Oxford’s PRINCIPLE Trial: Bringing Ivermectin Directly into the Developed World in the Battle Against COVID-19
  • Unitaid, Part of the World Health Organization Funding Ivermectin Research Targeting COVID-19 led by British Expert
    Unitaid, Part of the World Health Organization Funding Ivermectin Research Targeting COVID-19 led by British Expert

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.